Back
Third Harmonic Bio Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
79
THRD
Third Harmonic Bio
Last Price:
11.17
Seasonality Move:
-36.37%
Sell
16
NBY
NovaBay Pharmaceuticals
Last Price:
0.56
Seasonality Move:
-8.54%
Buy
79
Third Harmonic Bio (THRD)
is a Buy
Is Third Harmonic Bio a Buy, Sell or Hold?
- The current Third Harmonic Bio [THRD] share price is $11.83. The Score for THRD is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- THRD is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
16
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
THRD Stock Price Chart
What is Third Harmonic Bio's stock price today?
-
The Third Harmonic Bio share price today is $11.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and THRD is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
THRD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.34 | Sell |
| Relative Strength Index (14 RSI): | 45.7 | Sell |
| Chaikin Money Flow: | -45473 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.48 - 13.88) | Sell |
| Bollinger Bands (100): | (11.65 - 13.65) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 32.51 | Sell |
| Chaikin Money Flow: | -111892 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.58 - 0.72) | Sell |
| Bollinger Bands (100): | (0.35 - 0.97) | Sell |
THRD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.8 | Buy |
| 20-day SMA: | 12.22 | Sell |
| 50-day SMA: | 12.88 | Sell |
| 200-day SMA: | 12.2 | Sell |
| 8-day EMA: | 12.02 | Sell |
| 20-day EMA: | 12.32 | Sell |
| 50-day EMA: | 12.68 | Sell |
| 200-day EMA: | 12 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.58 | Sell |
| 20-day SMA: | 0.64 | Sell |
| 50-day SMA: | 0.65 | Sell |
| 200-day SMA: | 2.04 | Sell |
| 8-day EMA: | 0.58 | Sell |
| 20-day EMA: | 0.62 | Sell |
| 50-day EMA: | 0.68 | Sell |
| 200-day EMA: | 5 | Sell |
Third Harmonic Bio Earnings Growth & THRD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.35 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Third Harmonic Bio Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||